SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 73 filers reported holding SAVARA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,847 | -21.5% | 13,187 | -33.7% | 0.00% | – |
| Q2 2023 | $63,510 | +92.5% | 19,878 | +79412.0% | 0.00% | – |
| Q1 2022 | $33,000 | -50.0% | 25 | -47.9% | 0.00% | – |
| Q3 2021 | $66,000 | -99.5% | 48 | -99.3% | 0.00% | – |
| Q2 2021 | $12,282,000 | -69.9% | 7,225 | -63.2% | 0.00% | – |
| Q1 2021 | $40,843,000 | +326.3% | 19,636 | +135.7% | 0.00% | – |
| Q4 2020 | $9,580,000 | -15.9% | 8,330 | -20.3% | 0.00% | – |
| Q3 2020 | $11,390,000 | +43.9% | 10,450 | +228.7% | 0.00% | – |
| Q2 2020 | $7,916,000 | -70.7% | 3,179 | -75.1% | 0.00% | – |
| Q1 2020 | $27,022,000 | +28.7% | 12,746 | +171.9% | 0.00% | – |
| Q4 2019 | $20,998,000 | +66.5% | 4,687 | -1.5% | 0.00% | – |
| Q3 2019 | $12,609,000 | +65.7% | 4,758 | +48.2% | 0.00% | – |
| Q2 2019 | $7,610,000 | -82.7% | 3,211 | -46.3% | 0.00% | – |
| Q1 2019 | $44,036,000 | +383.0% | 5,975 | +631.3% | 0.00% | – |
| Q3 2018 | $9,118,000 | -1.4% | 817 | 0.0% | 0.00% | – |
| Q2 2018 | $9,248,000 | – | 817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,128,593 | $5,898,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,452,086 | $5,120,000 | 0.03% |
| Woodline Partners LP | 374,904 | $431,000 | 0.01% |
| Gyon Technologies Capital Management, LP | 19,679 | $23,000 | 0.01% |
| AXA S.A. | 1,895,554 | $2,180,000 | 0.01% |
| WEXFORD CAPITAL LP | 31,253 | $36,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 192,100 | $221,000 | 0.01% |
| Capital Advantage, Inc. | 14,658 | $18,000 | 0.01% |
| RGT Wealth Advisors, LLC | 10,000 | $12,000 | 0.00% |
| Crewe Advisors LLC | 3,910 | $4,000 | 0.00% |